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It is now established that vitamin A and its derivatives, retinoic acid (RA), are required for
cognitive functions in adulthood. RA hyposignaling and hyperactivity of glucocorticoid (GC)
pathway appear concomitantly during aging and would contribute to the deterioration of
hippocampal synaptic plasticity and functions. Furthermore, recent data have evidenced
counteracting effects of retinoids on GC signaling pathway. In the present study, we
addressed the following issue: whether the stimulation of RA pathway could modulate
intrahippocampal corticosterone (CORT) levels in middle-aged mice and thereby impact
on hippocampal plasticity and cognitive functions. We ﬁrstly investigated the effects of
vitamin A supplementation and RA treatment in middle-aged mice, on contextual serial
discrimination task, a paradigm which allows the detection of early signs of age-related
hippocampal-dependent memory dysfunction.We then measured intrahippocampal CORT
concentrations bymicrodialysis before and after a novelty-induced stress. Our results show
that both RA treatment and vitamin A supplementation improve “episodic-like” memory in
middle-aged mice but RA treatment appears to be more efﬁcient. Moreover, we show that
the beneﬁcial effect of RA on memory is associated to an increase in hippocampal PSD-95
expression. In addition, intrahippocampal CORT levels are reduced after novelty-induced
stress in RA-treated animals. This effect cannot be related to a modulation of hippocampal
11β-HSD1 expression. Interestingly, RA treatment induces a modulation of RA receptors
RARα and RARβ expression in middle-aged mice, a ﬁnding which has been correlated
with the amplitude of intrahippocampal CORT levels after novelty-induced stress. Taken
together, our results suggest that the preventive action of RA treatment on age-related
memory deﬁcits in middle-aged mice could be, at least in part, due to an inhibitory effect
of retinoids on GC activity.
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INTRODUCTION
Vitamin A, through its active metabolite retinoic acid (RA),
plays a key role in cognitive functions and more speciﬁcally
in hippocampus-dependent memory (Lane and Bailey, 2005;
McCaffery et al., 2006; Olson and Mello, 2010). Hippocampal
function in memory is dependent on plastic changes in synap-
tic strength, numbers of synapses and neurons, all of which
can be modulated by RA (McCaffery et al., 2006). RA regu-
lates gene expression including plasticity-related genes through
binding to speciﬁc nuclear receptors: RA receptors (RARs) or
retinoic X receptors (RXRs; Marill et al., 2003). When the RARs
are functionally removed by mutation in mice, deﬁcits both in
long-term potentiation and in hippocampal-dependent memory
tasks are observed (Chiang et al., 1998; Wietrzych et al., 2005).
These deleterious effects have been also evidenced by using the
vitamin A deﬁciency (VAD) model in rats and mice, a nutritional
approach leading to a speciﬁc hyposignaling of RA signaling path-
way (Cocco et al., 2002; Etchamendy et al., 2003; Bonnet et al.,
2008). The disruption of retinoid signaling pathway that result
from a hypoexpression of some retinoid receptors in target tis-
sues including the hippocampus, occurs naturally during aging
in rodents and humans (Enderlin et al., 1997; Etchamendy et al.,
2001; Feart et al., 2005; Mingaud et al., 2008; Touyarot et al.,
2013). Moreover, it is well established that this RA hyposignal-
ing contributes to the deterioration of hippocampal plasticity and
memory processes during aging and these deleterious effects could
be reversed by a vitamin A supplementation or RA treatment
(Etchamendy et al., 2001; Mingaud et al., 2008; Touyarot et al.,
2013).
Although the involvement of retinoids in the modula-
tion of hippocampal plasticity and functions has been well
described in aged rodents, molecular mechanisms underlying
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these effects remain unclear. The hippocampus is a prime target
for glucocorticoids (GCs) which bind to abundant mineralocor-
ticoid and GC receptors (MRs and GRs, respectively), known to
be involved in the control of hippocampal plasticity and func-
tions (Oitzl and de Kloet, 1992). During aging, hyposignaling of
vitamin A pathway occurs concomitantly with hyperactivity of
GC pathway leading to excess plasma levels of GCs [cortisol for
humans and corticosterone (CORT) for rodents; Born et al., 1995;
Tronche et al., 2010] probably due to alterations in the regulation
of hypothalamic–pituitary–adrenal (HPA) axis (Mizoguchi et al.,
2009). However, although elevated levels of plasma CORT have
been largely hypothesized to contribute to age-related memory
decline (Cameron and Gould, 1994; Lupien et al., 1998; Yau and
Seckl, 2012), few studies focus on the measurement of intrahip-
pocampal CORT levels in aged rodents in relation to memory
retrieval performance. Interestingly, it has been recently shown
that stress-induced intrahippocampal CORT rise in middle-aged
rats was associated with memory impairments in a hippocampal-
dependent memory task (Chauveau et al., 2009b) that has been
previously shown to be affected in middle-aged mice (Celerier
et al., 2004; Beracochea et al., 2008a,b; Chauveau et al., 2009a,b;
Pierard et al., 2009; Tronche et al., 2010). The magnitude of intra-
cellular CORT action in the rodent hippocampus is thought to
be determined by the hippocampal activity of 11β-hydroxysteroid
dehydrogenase type 1 (11β-HSD1), an enzyme that regenerates
active CORT within cells, but also by free CORT circulating in
blood and delivered to the brain (Seckl, 1997). Thus, both the
hyperactivity of hippocampal 11β-HSD1 and the alterations of
HPA axis leading to elevated plasma CORT, have been correlated
with impairments in hippocampal-dependent memory tasks dur-
ing aging (Yau et al., 2001; Holmes et al., 2010; Yau and Seckl,
2012).
While the antagonism between GCs and RA pathways has been
suggested in few studies using different cell types (Paez-Pereda
et al., 2001; Aubry and Odermatt, 2009; Brossaud et al., 2013), no
study has scrutinized the regulation of GCs activity by retinoids
and its impact on cognitive functions in aged animals. Interest-
ingly, inhibitory effects of RA and vitamin A supplementation
have been evidenced on the expression and the activity of 11β-
HSD1, in differentiated C2C12 myotubes (Aubry and Odermatt,
2009) and in obese rats liver (Sakamuri et al., 2011). Finally, it has
been recently evidenced an increased HPA axis activity in basal
and stress conditions associated with an up-regulation of the hip-
pocampal expression of 11β-HSD1 in vitamin A deﬁcient LOU/C
rats, which have been normalized by RA treatment (Arvy et al.,
2013).
Altogether, these data suggested counteracting effects between
RA and GCs pathways. In the present study, we addressed whether
the stimulation of RA pathway could modulate intrahippocampal
CORT levels in middle-aged mice and thereby modify hippocam-
pal plasticity and cognitive functions.Weﬁrst compared the effects
of vitamin A supplementation (20 IU/g retinol, 2 months) and
RA treatment (150 μg/kg, 5 days) on memory retrieval of the
contextual serial discrimination (CSD) task in middle-aged mice.
Thus, we show that short-term RA treatment in middle-aged mice
induced an improvement on memory retrieval associated with an
increased hippocampal PSD-95 (postsynaptic scaffolding protein
95 kDa) mRNA expression, used as a marker of synaptic plastic-
ity. Hence, we measured intrahippocampal CORT concentrations
(by microdialysis), in basal conditions and after CSD box-induced
stress. We demonstrated for the ﬁrst time that RA treatment sig-
niﬁcantly decreased and delayed the stress-induced increase of
hippocampal CORT levels observed in middle-aged mice without
any effect on basal concentration. Therefore, our results strength-
ened the hypothesis of a close relationship between vitamin A
status and GCs-induced cognitive impairments in middle-aged
mice. Thus, acting on vitamin A status could be a good strategy
to prevent excess GCs-induced cognitive decline occurring with
aging.
MATERIALS AND METHODS
ANIMALS
Middle-aged (Mid-age) C57BL/6 Jico mice (12-month-old) were
purchased from Janvier (Le Genest-Saint-Isle, France). They
were housed in a collective cage in a room with a constant
airﬂow system, controlled temperature (21–23◦C), and a 12-h
light/dark cycle. Mice were granted ad libitum access to food
and water and were randomly divided into two experimental
groups. One group (n = 22) was fed with a control diet con-
taining 5 IU retinol/g or a vitamin A-enriched diet containing
20 IU retinol/g during 2 months (INRA, Jouy-en-Josas). The sec-
ond group (n = 39) was fed with a control diet containing 5 IU
retinol/g (INRA, Jouy-en-Josas) during 2 months and received
subcutaneous injections of RA or vehicle. One week prior to the
experiments, all animals were individually housed until sacriﬁce.
Mice were handled and deprived during this period: all subjects
were daily weighed in order to maintain 90% of their ad libitum
body weight throughout the behavioral study. All experiments
were performed in accordance with the European Communities
Council Directives (86/609/EEC) and the French National Com-
mittee (87/848) recommendations, and have been approved by
the Animal Care and Use Committee of Bordeaux under the
N◦50120169-A.
DIET
A ﬁrst group of middle-aged mice (Mid-age, n = 12) was fed with
a control diet containing 5 IU retinol/g (INRA, Jouy-en-Josas)
during 2 months. The second half (Mid-age +Vitamin A, n = 10)
received the vitamin A-enriched diet (20 IU retinol/g) during the
same period. The composition of the control diet was the same
as the vitamin A-enriched diet, except for retinol content. The
20 IU diet was chosen on the basis of literature as a moderate
supplementation to avoid potential toxicity of hypervitaminosis
(for review, see Penniston and Tanumihardjo, 2006). Diets started
as soon as mice arrived in the laboratory (i.e., at the age of 12–13
months) and continued throughout the entire experiment.
RA TREATMENT
Middle-aged treated group (12-month-old, n = 39) was fed with a
control diet containing 5 IU retinol/g (INRA, Jouy-en-Josas) dur-
ing 2 months and divided into two groups: one group received
daily subcutaneous injections of the vehicle (Mid-age + vehicle,
n = 20), and the second group received RA treatment (Mid-
age + RA, n = 19). RA (150 μg of all-trans-RA/kg body weight,
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Sigma, France) was dissolved in a mixture (vehicle) contain-
ing polyethylene glycol–NaCl–ethanol (70:20:10, by volume) and
injected during 5 days. This dose of RA was shown to be effective
in reversing age-related hypoexpression of brain signaling and its
associatedmemory impairment inmice (Etchamendy et al., 2001).
EXPERIMENTAL DESIGN
Experimental design displayed in Figure 1
In the ﬁrst experiment, we tested the effects of 2 months of nutri-
tional vitamin A supplementation administered to 12-month-old
mice on memory in the CSD task. Thus, after 2 months of diet,
middle-aged mice (Mid-age, n = 12) and enriched middle-aged
mice (Mid-age + Vitamin A, n = 10) were tested in the CSD
task.
In the second experiment, we tested the effects of RA treatment
during 5 days started at middle-age (14-month-old) on memory
and hippocampal plasticity. Mice were divided into two groups:
mice injected with vehicle are referred to as Mid-age + vehicle
(n=13) andmice injectedwithRAare referred to asMid-age+RA
(n = 13). Mice were injected 4 days (one injection/day) before
the acquisition phase of the CSD task and until the test phase
which occurred 24-h later. Twenty minutes after the end of the
test phase, all groups were sacriﬁced and hippocampi were quickly
dissected in order to study the expression of plasticity-related RA
target genes by quantitative RT-qPCR [Synaptophysin, RC3, GAP-
43 (growth-associated protein 43 or neuromodulin), PSD-95].
In the third experiment, the effects of RA treatment were
studied on hippocampal CORT release after CSD box-induced
stress in 14-month-old mice. Similarly as in Experiment 2, mice
were divided into Mid-age + RA (n = 7) and Mid-age + vehicle
(n = 6). After ﬁve consecutive days of injections, at the same time
of behavioral testing, microdialysis experiment was performed.
FIGURE 1 | Experimental design. Three experiments are carried out.
Experiments 1 and 2 are designed to compare the effects of vitamin
A supplementation and RA treatment on memory retrieval in the
contextual serial discrimination (CSD) task. The Experiment 3 aims to
determine the effects of RA treatment on hippocampal CORT relevels
in novelty-induced stress. At the end of the Experiments 2 and 3,
animals are euthanized, hippocampi and half-brain were dissected in
order to carry out RT-PCR measurement (Experiments 2 and 3) and
histological control of guide cannula implantation (Experiment 3). The
arrows and the bars indicate the time spent and the diet received,
respectively. Each needle represented one daily injection of RA or
vehicle treatment.
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After a basal period which lasted 60 min in the microdialysis bowl,
animals were placed in the CSD-like box for 10 min and cere-
brospinal ﬂuid (CSF) was collected during 105 min post-stress
period. Twenty-four hours later, animals were sacriﬁced and hip-
pocampi were collected in order to evaluate the expression of
retinoid receptors (RARs) and GCs-related RA target genes as
11β-HSD1.
Contextual serial discrimination task apparatus
The CSD task has been extensively described in earlier studies
(Celerier et al., 2004; Beracochea et al., 2008a,b; Chauveau et al.,
2009a,b). All tests were performed in a 4-hole board appara-
tus (45 cm × 45 cm × 30 cm high) enclosed by gray Plexiglas.
The 4-hole board apparatus was placed on the ﬂoor of the room
(3.0 m × 3.0 m × 2.40 m high). The ﬂoor of the board was
interchangeable (white and rough; black and smooth). On the
ﬂoor, four holes opening on a food cup (3 cm diameter, 2.5 cm
in depth) were located 6 cm away from the side-walls. The appa-
ratus was placed in a room exposed to a 60-dB background noise
and a light centered over the apparatus provided 20 lux inten-
sity at the position of the apparatus. The apparatus was cleaned
with 95% ethanol, then with water before each mouse behavioral
testing. Data were automatically monitored by photoelectric cells
and video recording.
Acquisition phase
In the CSD, the acquisition phase took place in room A where
animals learned two consecutive spatial discriminations (D1 and
D2; see Figure 2). Both discriminations differed in terms of the
color and texture of the ﬂoor (internal context of the 4-hole
board) and were separated by a 2-min delay interval. During
this delay, the mouse was returned to its home cage in room B.
At the beginning of acquisition and retrieval phases, mice were
placed in the center of the 4-hole board in an opaque PVC tube
for 5 s to provide the animal with a random start in the appa-
ratus. For D1, ten 20-mg food pellets were available only in one
of the four holes on the board for 6 min. Location of the baited
hole for D1 was randomized for each subject. For D2, ten 20-mg
food pellets were consistently located in the opposite symmetri-
cal hole, for 6 min likewise. The environmental spatial cues were
made of colored and striped paper sheets positioned at 1.00 m
above the 4-hole board. These allocentric cues remained at the
same place for both D1 and D2 discriminations and for the
retrieval phase. Thus, both discriminations D1 and D2 differed
FIGURE 2 | Experimental procedures. (A) Experimental procedure of the
contextual serial discrimination (CSD) behavioral task. D1, discrimination
1; D2, discrimination 2. During retrieval test phase, each mouse is
evaluated on D1 ﬂoor without food reward. (B) Detailed description of
microdialysis procedure. Time 0 (T0) corresponds to the last point of
the basal period (pre-stress) just before the beginning of the exploration
in the CSD-like box. This novelty-induced stress induces an increased
hippocampal CORT levels. Thus, microdialysates collected at time 15
(post-stress) corresponds to the CORT levels released between 0 and
15 min after stress.
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only by way of the internal (ﬂoor) contextual cues. Both ﬂoors
were positioned in a mixed random order during the acquisi-
tion of the ﬁrst and second discrimination tasks. At the end of
the acquisition phase, mice returned to their home cage in the
animal room for 24 h. Only mice having eaten all the pellets
during both acquisition sessions were used for the retrieval test
phase.
Test phase
Twenty-four hours after the acquisition phase, mice were replaced
in the 4-hole board (roomA) without any pellets in the apparatus.
Micewere placedon theD1ﬂoor andwere allowed to freely explore
the apparatus for 6 min. Performance was assessed by measuring
the number of head-dips in each hole during 6 min.
Measurements
Memory retrieval performance was evaluated through the explo-
ration rates into the different holes. Correct responses were
deﬁned as head-dips into the hole previously baited on the
same ﬂoor-context during the acquisition phase, and were cal-
culated as follows: (head-dips into the baited hole/total number
of head-dips in the four holes) × 100. Interfering responses
were deﬁned as head-dips into the hole previously baited on
the other ﬂoor-context in the acquisition phase and were cal-
culated on same manner as correct responses. Chance level
was 25%.
SURGERY AND HISTOLOGY
For Experiment 3, 1 week before the microdialysis study, mice
were anesthetized with a ketamine (100 mg/kg body weight)–
xylazine (10 mg/kg body weight) solution and placed into a
stereotaxic frame. A single guide cannula microdialysis (CMA/7
Microdialysis probe, CMA Microdialysis, Sweden) was implanted
randomly in the left or the right hemisphere, in the bottom of
the parietal cortex at the following coordinates from the bregma
(Paxinos and Franklin, 2001): anteroposterior = −2000 μm, lat-
eral = ±1400 μm, and vertical = −900 μm. The guide cannula
was ﬁxed with dental cement to the skull. All operated mice
were allowed to recover in their home cages in the animal room
for at least 7 days before the microdialysis experiment. On the
day of experiment, the microdialysis probe was lowered 1 mm
below through the guide cannula so that the microdialysis mem-
brane is located into the dorsal hippocampus. At the end of
the microdialysis experiment, mice were euthanatized and the
half of the brain containing the guide cannula was dissected,
washed into a saline solution (NaCl 0.9%) and postﬁxed in a
4% paraformaldehyde solution. After 3 weeks postﬁxation period,
50 μm frontal sections were cut on a vibratome (Leica). A cresyl
violet stain was used to locate the microdialysis probe with utmost
accuracy.
IN VIVO MICRODIALYSIS
Seven days after surgery, a dialysis probe (CMA/7; CMA Micro-
dialysis AB, Sweden; length: 1 mm; molecular cut-off 6 kDa
and membrane diameter: 0.24 mm outer diameter) was care-
fully implanted into the right or left dorsal hippocampus. Mice
were then individually housed in a system allowing animals
to move freely (CMA/120; CMA Microdialysis AB, Sweden)
overnight. After the overnight perfusion at 0.5 μL/min, freely
moving animals were continuously perfused with a sterile-ﬁltered
saline solution (Dulbecco’s phosphate buffered saline; SIGMA;
in g/L: CaCl2, 0.133; MgCl2, 0.1; KCl, 0.2; KH2PO4, 0.2;
NaCl 8.0; Na2HPO4, 1.15; pH between 7.1 and 7.5) at a 1-
μL/min ﬂow rate through a micro-infusion pump. Baseline
dialysates were collected for 60 min before novelty-induced stress
task. During the novelty-induced stress, animals were carefully
placed in an open ﬁeld square box similar to the CSD box
(45 cm × 45 cm × 30 cm high). After 10 min exploration,
animals were then relocated in the microdialysis freely moving
chamber for 95 min. Microdialysates were sampled every 15 min
using tubes with a dead volume of 1.2 μL/100 mm length (CMA
Microdialysis AB). Samples were stored at 80◦C. Free CORT lev-
els measured in the dialysates (in nM) were expressed as the
percentage of the averaged baseline values collected before the
injection.
INTRA-HIPPOCAMPAL CORT ASSAY
A commercially prepared Enzyme Immunoassay kit was used
to measure HPC CORT concentrations in the microdialysates
(Correlate-EIATM , Assay Designs, Ann Arbor, USA) according
to the manufacturer’s instructions. The sensitivity of the assay was
0.08 nmol/L. Therefore, baseline sample concentration was more
than 10-fold superior than sensitivity threshold.
REAL-TIME qPCR ANALYSIS OF TARGET GENE EXPRESSION IN THE
HIPPOCAMPUS
The other half of the hippocampus was used to measure gene
expression. Extraction of RNA was conducted using an extraction
kit (TRIzol reagent, Invitrogen, Saint Aubin, France) according
to the manufacturer’s instructions. The integrity of the puri-
ﬁed RNA was veriﬁed using the RNA 6000 Nano LabChip kit
in combination with the 2100 bioanalyzer (Agilent Technolo-
gies). The concentrations of RNA were determined by using
a nanodrop (ND-1000; Labtech). Using OligodT and random
primers (Promega, Charbonnières-les-Bains, France), cDNA was
synthesized from 1 μg of RNA with ImPromII reverse tran-
scriptase (Promega, Charbonnières-les-Bains, France) according
to the manufacturer protocol. The real-time qPCR was per-
formed using the LightCycler 480 system with a 96-well format
(Roche Diagnostics) in a volume, containing 1× LightCycler
480 SYBR Green I Master solution, 0.5 μM of each primer and
6 μL of cDNA. The forward and reverse primer sequences are
summarized in Table 1. The results are expressed as the tar-
get/reference ratio divided by the target/reference ratio of the
calibrator.
STATISTICAL ANALYSIS
Contextual serial discrimination test and RT-qPCR data were ana-
lyzed by a one-way analysis of variance (ANOVA): effect of vitamin
A or RA treatment. Comparisons of retrieval performance with
chance level were calculatedwith a one sample t-test (with hypoth-
esized mean = chance level = 25%). Hippocampal CORT release
was analyzed using a two-way ANOVA with repeated measures:
effect of RA treatment and Time. All results were expressed as
mean ± SEM.
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Table 1 | Primers used for LightCycler RT-qPCR.
Gene name Nucleotide sequence 5′–3′ Product
length (bp)
GAPDH F: CCAGTGAGCTTCCCGTTCA 78
R: GAACATCATCCCTGCATCCA
Actin F: AAAACGCAGCTCAGTAACAGTCC 220
R: AGGATGCAGAAGGAGATTACTGC
Synaptophysin F: TCCTTGCATGTGTTTCCTGTCTG 137
R: GCAGTGTTCGCTTTCATGTGG
PSD-95 F: TGGATCACAGGGTCGAGAAG 101
R: CTTTGGTAGGCCCAAGGATG
RC3 F: CACTCTCCGCTCTTTATCTTCTTC 127
R: GCTCCAAGCCAGACGACGATATTC
GAP-43 F: GGGGAGTTATCAGTGGTAGC 255
R: GTGATGCACCAGCTGCTGAGG
RARα F: GGCGAACTCCACAGTCTTAATG 118
R: GCTGGGCAAGTACACTACGAAC
RARβ F: GGGGTATACCTGGTACAAATTCTGA 227
R: CAGCTGGGTAAATACACCACGAA
RARγ F: CCCAAGGATGCTGATGAAAATC 63
R: GCCCTTTCTGCTCCCTTAGTG
11β-HSD1 F: GGAAGGTCTCCAGAAGGTAGTGTC 51
R: GAGGCTGCTCCGAGTTCAAG
Sequences are shown for forward (F) and reverse (R) primers. GAPDH,
glyceraldehyde-3-phosphate dehydrogenase-like; PSD-95, postsynaptic density
protein 95; RC3, neurogranin; GAP-43, growth associated protein 43; RARs,
retinoic acid receptors; 11β-HSD1, 11-beta-hydroxysteroid dehydrogenase type 1.
RESULTS
EFFECTS OF VITAMIN A SUPPLEMENTATION AND SHORT-TERM RA
TREATMENT ON CONTEXTUAL SERIAL DISCRIMINATION MEMORY
In the present experiment, we compared the effects of 2 months of
vitamin A supplementation and short-term RA treatment on D1
retrieval in middle-aged mice (Figure 3).
Acquisition phase
The acquisition phase of groups tested forD1was analyzed accord-
ing to the further random attribution of mice to different diet
or treatment conditions (Control vs Vitamin A, Vehicle vs RA).
No between-group difference was observed on behavioral mea-
sures (number of head-dips into baited holes, total number of
head-dips; n.s. in all comparisons – data not shown).
Retrieval test phase – correct responses
As shown in Figure 3A, one-way ANOVA of percentage of cor-
rect responses in D1 retrieval test revealed no effect of vitamin
A supplementation [F(1,20) = 3.23, p = 0.087; Mid-age + Vita-
min A: 38.59 ± 3.81% vs Mid-age: 30.26 ± 2.80%]. However,
the enriched middle-aged group exhibited performances signif-
icantly above the chance level (different from 25%; one sample
test p < 0.01) compared to control middle-aged mice which
performed at chance (one sample test p = 0.087, n.s.). As shown
in Figure 3B, a signiﬁcant improvement of memory retrieval was
observed in middle-aged mice receiving RA treatment compared
to the vehicle-treated group [F(1,24) = 25.32, p < 0.001; Mid-
age + RA 50.66 ± 3.16% vs Mid-age + vehicle: 25.68 ± 3.82%].
In addition, D1 performance of RA-treated mice was signiﬁcantly
above the chance level (one sample test p < 0.0001) showing that
they accurately remember the previously baited hole, in contrast
to vehicle-treated mice.
Retrieval test phase – interfering responses
During retrieval of D1, interfering responses consisted of explo-
ration into the hole baited on discrimination D2. As shown in
Figure 3C, one-way ANOVA analyzes revealed that vitamin A
supplementation does not affect the percentage of responses in
the interfering hole [F(1,20) = 3.18, p = 0.90; Mid-age +Vitamin
A: 27.48 ± 4.29% vs Mid-age 36.98 ± 3.31%]. However, as seen in
Figure 3D, one-way ANOVA showed that RA-treated mice exhib-
ited signiﬁcantly less interfering responses than vehicle control
mice [F(1,24) = 15.18, p < 0.001; Mid-age + RA: 21.88 ± 2.20%
vs Mid-age + vehicle: 39.42 ± 3.93%]. In addition, the percent-
age of responses in the interfering hole was above the chance level
for the vehicle-treated mice (one sample test p = 0.003) conﬁrm-
ing impaired contextual retrieval for D1, whereas RA-treated mice
performed at chance (one sample test p = 0.182, n.s.).
In conclusion, our results demonstrate that both vitaminA sup-
plementation and RA treatment improve memory performances
in the CSD task. However, a short-term RA treatment in middle-
aged subjects was more efﬁcient to improve retrieval of D1 context
than 2 months of vitamin A supplementation. Thus, short-term
RA treatment was chosen in our subsequent experiments to study
the effects of retinoid pathways stimulation in middle-aged mice
on hippocampal CORT levels and hippocampal expression of
retinoid-target genes.
EFFECTS OF RA TREATMENT ON HIPPOCAMPAL EXPRESSION OF
PLASTICITY-RELATED GENES
In order to study the possible neurobiological mechanisms under-
lying the improvement of memory performances in RA-treated
mice, we tested whether RA treatment can modulate expression of
some hippocampal plasticity genes such as synaptophysin, PSD-
95, RC3 (neurogranin), and GAP-43, measured 20 min after the
end of the CSD task. As shown in Figure 4, one-way ANOVA per-
formed on mRNA expression of hippocampal PSD-95 revealed
an effect of RA treatment [F(1,9) = 10.46, p = 0.01]. Indeed, an
increase of PSD-95 expression (+13%) was found in RA-treated
mice. However, no effect of RA treatment was found on themRNA
expression of synaptophysin, RC3, and GAP-43 [F(1,9) = 0.008,
n.s., F(1,9) = 1.90, n.s., and F(1,9) = 0.009, n.s., respectively].
EFFECTS OF RA TREATMENT ON HIPPOCAMPAL CORT RELEASE
Westudied the involvement of hippocampalCORT in the effects of
RA treatment on hippocampal plasticity and functions in middle-
aged mice. Thus, CORT levels in hippocampal dialyzates were
analyzed in basal conditions and after CSD box-induced stress
according to the further random attribution of mice to vehicle or
RA-treated groups.
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FIGURE 3 | Effects of vitamin A supplementation and RA treatment on
D1 retrieval. (A) The percentage of correct responses for vitamin A
supplemented group was different from the chance level (25%) compared
to control group. (B) The percentage of correct responses for RA-treated
group was increased compared to vehicle and different from chance level.
(C) The percentage of interfering responses for vitamin A supplemented
group was not signiﬁcantly different from chance level compared to control
group. (D) Percentage of interfering responses for RA-treated group was
signiﬁcantly decreased compared to vehicle and was not different from
chance level. ***p < 0.001 vs Control by one-way ANOVA; ##p < 0.01 vs
Chance, ###p < 0.001 vs Chance, by one sample t -test. n = 10–13 per
group.
FIGURE 4 | Effects of RA treatment on mRNA expression of
hippocampal plasticity-related genes. RA treatment signiﬁcantly
increases PSD-95 mRNA levels. No difference between groups was
detected for Synaptophysin, RC3, and GAP-43 mRNA levels. **p < 0.01 vs
Control; by one-way ANOVA, n = 6 per group.
As shown in Figure 5A, a photomicrograph of coronal brain
section stained with cresyl violet from a typical mouse shows that
microdialysis probe were located inside the dorsal hippocampus,
between CA1 and DG areas. Figure 5B represents CORT levels in
the dorsal hippocampus and results are expressed in percentage of
variation of baseline.
Basal hippocampal corticosterone levels
Two-wayANOVA on hippocampal CORT levels (Figure 5B) along
the basal period (−60 to 0 min) evidenced no global effect of
treatment [F(1,11) = 1.77, n.s.], nor interaction treatment × time
[F(4,44)= 1.00, n.s.] showing no differences in basal hippocampal
CORT between groups (Mid-age + vehicle: 1.11 ± 0.20 nM vs
Mid-age + RA: 1.61 ± 0.37 nM.)
Hippocampal corticosterone levels after CSD box-induced stress
Two-way ANOVA performed on hippocampal CORT released
along the post-stress period (from 0 to 105 min) revealed a global
effect of RA treatment [F(1,11) = 4.54, p = 0.05], an effect of
time [F(7,77) = 4.43, p < 0.0001] with an interaction treat-
ment × time [F(7,77) = 2.47, p < 0.05]. Firstly, as compared
to the last pre-stress sample (121.08 ± 7.66%; time 0), stress
induced a fast and rapid increase in CORT levels from 15 min
after stress (165.36 ± 16.58%) to 105 min (220.55 ± 32.15%)
in vehicle-treated mice. Moreover, a faster increase in CORT
levels was observed 15 min after CSD box-induced stress in
control middle-aged mice as compared to RA-treated middle-
aged mice [F(1,11) = 3.91, p = 0.07; Mid-age + vehicle:
165.36 ± 16.58% vs Mid-age + RA: 114.93 ± 18.80%] as well
as 30 min [F(1,11) = 4.04, p = 0.07; Mid-age + vehicle:
192.71 ± 38.7% vs Mid-age + RA: 116.50 ± 11.97%], 45 min
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FIGURE 5 | Effects of RA treatment on hippocampal CORT release.
(A) Histological control of intra-hippocampal microdialysis probe
implantation. Photomicrograph (×20) of coronal brain section stained
with cresyl violet. Stereotaxic coordinates from bregma:
AP = −2000 μm, L = ±1400 μm, and V = −900 μm. (B)
Hippocampal CORT concentration was similar for all groups during basal
period. During post-stress period, RA-treated group showed a decrease
in hippocampal CORT levels particularly at 45 and 60 min after stress.
*p < 0.05, **p < 0.01, by two-way ANOVA with repeated measures
and one-way ANOVA, n = 6–7 per group.
[F(1,11) = 5.56, p < 0.05; −78% between Mid-age + vehicle:
218.48 ± 34.42% and Mid-age + RA: 140.26 ± 9.22%] and 60 min
[F(1,11) = 11.43, p < 0.01; −77% between Mid-age + vehicle:
218.8 ± 18.88% and Mid-age + RA: 151.36% ± 9.05%] after
stress delivery.
Thus, CSD box-induced stress signiﬁcantly increased hip-
pocampal CORT levels in middle-aged rats but the stress-induced
CORT rise was lower and delayed for an extended period of time
in RA-treated middle-aged mice.
EFFECTS OF RA TREATMENT ON HIPPOCAMPAL EXPRESSION OF
RETINOID RECEPTORS AND 11β-HSD1
In order to study the relationships between retinoid and GC path-
way, hippocampal expression of RARs and 11β-HSD1was assessed
in middle-aged mice. For gene expression, results are expressed in
percentage of variation by comparison to vehicle-treated group.
As seen in Figure 6A, one-way ANOVA performed on hip-
pocampal RARα mRNA expression showed an effect of RA
treatment [F(1,10) = 19.16, p < 0.01]. Indeed, RA treatment
induced a decreased RARα expression (−14%) compared to
vehicle-treated mice. By contrast, hippocampal RARβ mRNA
expression is increased by 38% compared to vehicle-treated mice
[ANOVA, effect of RA treatment, F(1,10) = 53.88, p < 0.001].
Finally, no effect of RA treatment was detected on hippocampal
RARγ expression [F(1,10) = 0.55, n.s.]. As shown in Figure 6B,
hippocampal mRNA expression of 11β-HSD1 was not affected by
RA treatment [F(1,10) = 0.32, n.s.].
Moreover, correlations analyzes were performed between hip-
pocampal expression of RARs and intrahippocampal CORT levels
in order to study interactions between RA and GCs signal-
ing pathways (Figure 7). Correlation analyzes between hip-
pocampal expression of RARα and CORT levels showed that a
decreased expression of RARα was associated to a lower hip-
pocampal CORT release 45 and 60 min post-stress (Figures 7A,B,
r = 0.55, p < 0.05 and r = 0.59, p < 0.05, respectively).
FIGURE 6 | Effects of RA treatment on hippocampal expression of
RARs (RARα, RARβ, RARγ) and 11β-HSD1. (A)The percentage of RARα
mRNA expression was decreased by RA treatment whereas the
percentage of RARβ mRNA expression was increased by the treatment. No
effect on RARγ expression was found. (B) RA treatment did not modulate
hippocampal mRNA levels of 11β-HSD1. By one-way ANOVA, n = 6–7 per
group. ***p < 0.001 vs Mid-age + Veh; **p < 0.01 vs Mid-age + Veh, by
one-way ANOVA, n = 6–7 per group.
Moreover, correlation analyzes revealed a strong negative corre-
lation between intrahippocampal CORT levels and hippocampal
expression of RARβ 45 and 60 min post-stress (Figures 7C,D,
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FIGURE 7 | Relationships between hippocampal expression of RARs
(RARα, RARβ) and intrahippocampal CORT levels. (A,B) Correlation
analyzes between RARα and CORT levels. Intrahippocampal CORT
levels [45 min (A) and 60 min (B) post-stress] positively correlated
with RARα hippocampal mRNA expression (r = 0.55, p < 0.05 and
r = 0.59, p < 0.05, respectively). (C,D) Correlation analyzes between
RARβ and CORT levels. Intrahippocampal CORT levels [45 min (C) and
60 min (D) post-stress] negatively correlated with RARβ hippocampal
mRNA expression (r = 0.64, p < 0.01 and r = 0.57, p < 0.05,
respectively).
r = 0.64, p = 0.01 and r = 0.57, p < 0.05, respectively): low
intrahippocampal CORT was associated with elevated expres-
sion of RARβ. Finally, no signiﬁcant correlation was found
between hippocampal CORT levels and hippocampal RARγ
expression.
Thus, these data sustained the idea that the modulation of RA
signaling pathway by RA treatment during mid-life can modulate
GCs activity in the hippocampus.
DISCUSSION
The aim of this study was to explore the involvement of retinoids
in the modulation of intrahippocampal CORT levels in middle-
aged mice and its impact on hippocampal plasticity and functions.
Middle-aged mice treated with ﬁve daily consecutive injections of
RA retrieve better D1 discrimination in CSD task than mice fed
with 2 months of vitamin A supplementation showing that RA
treatment seems to be more efﬁcient than vitamin A supplemen-
tation. Moreover, we show that the improvement of D1 retrieval by
RA treatment is associatedwith an increased hippocampal PSD-95
mRNA expression, one of plasticity-related RA target genes. Inter-
estingly, RA treatment can decrease and delay the stress-induced
increase in dorsal hippocampus CORT rise in middle-aged mice.
This effect cannot be related to a modulation of hippocam-
pal 11β-HSD1 expression. In addition, RA treatment induces
a modulation of RA receptors RARα and RARβ expression in
middle-agedmice,which has been correlatedwith intrahippocam-
pal CORT levels after CSD-box-induced stress, showing that
retinoid signaling could be an important modulator of intrahip-
pocampal GCs activity and thereby hippocampal plasticity and
functions.
EFFECTS OF RETINOIC ACID TREATMENT ON CSD TASK AND
HIPPOCAMPAL EXPRESSION OF PLASTICITY-RELATED TARGET GENES
AT MIDDLE-AGE
We ﬁrst explored the effects of vitaminA supplementation and RA
treatment on CSD task that allows the detection of early signs of
age-related hippocampal-dependent memory deﬁcits (Chauveau
et al., 2010; Tronche et al., 2010). Studies inmiddle-agedmice have
important implications for the treatment of the non-pathological
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age-associated cognitive decline, as well as mild cognitive impair-
ment (Pepeu, 2004). The effects of stimulation of retinoid pathway
on memory performance have not yet been tested in middle-aged
rodents. Thus, our study demonstrates for the ﬁrst time that a
mid-life RA treatment is efﬁcient to correct “early” age-related
hippocampal-dependent memory deﬁcits. The ability of cells to
convert vitamin A into RA, the active metabolite, and there-
fore to initiate retinoid signaling would be altered during aging
(Azais-Braesco et al., 1995). Thus, injections of RA at middle-age,
would be more efﬁcient than 2 months of nutritional vitamin
A supplementation involving metabolization steps. Our present
results show that 2 months of vitamin A supplementation with
a dose of 20 IU retinol/g is not sufﬁcient to observe preventive
effects on memory processes. However, a recent study of our
team has shown that the stimulation of retinoid pathway by 4
months of vitamin A supplementation allowed the correction of
hippocampal-dependent memory deﬁcits in aged rodents but in
this study, the animals were fed with higher content of vitamin
A (45 IU retinol/g) and for a longer time which would be an
efﬁcient way of improving metabolism (Etchamendy et al., 2001;
Drapeau et al., 2003, 2007; Mingaud et al., 2008; Touyarot et al.,
2013).
In our current study, the memory retrieval improvement of
D1 observed in middle-aged mice after RA treatment can be
ascribed to an improvement of hippocampal-dependent mem-
ory function. Indeed, mice with lesion of the dorsal hippocampus
exhibited an impaired memory retrieval pattern in the CSD task
similar to that of middle-agedmice of the present study (Chauveau
et al., 2009b). Deﬁcits in hippocampal-dependent tasks reported
in middle-aged rats (Frick et al., 1995; Markowska and Breckler,
1999; Kadish et al., 2009), could result from dysfunction of hip-
pocampal plasticity (Kaczorowski and Disterhoft, 2009). Thus,
the modulation of hippocampal plasticity, one plausible mecha-
nism underlying hippocampal memory function would be critical
for retention of D1 discrimination in the CSD task. The genes
we chose to study are hippocampal plasticity-related RA target
genes and all major components of presynaptic and postsynaptic
density. Thus, we show that RA treatment is efﬁcient not only
to improve hippocampal-dependent memory processes but also
hippocampal synaptic plasticity as evaluated by the expression of
someplasticity-relatedRA target genes inmiddle-agedmice. Inter-
estingly, we demonstrate that RA treatment at mid-life increased
hippocampal PSD-95 mRNA expression, known to be involved
in memory processes (Migaud et al., 1998; Carlisle et al., 2008).
PSD-95 recruits and clusters N-methyl-D-aspartate (NMDA) and
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)
receptors, ion channels, cytoskeletal components, and signal trans-
duction molecules in response to synaptic activity (Beique et al.,
2006; Vickers et al., 2006). During spatial learning and memory
formation, PSD-95 is recruited to synaptic lipid rafts, suggesting
that regulated localization as well as expression of this protein is a
necessary component of synaptic plasticity (Delint-Ramirez et al.,
2008). Alterations in the content of PSD-95 in the hippocam-
pal formation have been observed in aged-learning impaired
rats (Nyffeler et al., 2007). In addition, a positive correlation
between the decreased expression levels of hippocampal PSD-
95 and the decline of performance in a hippocampal-dependent
spatial memory task have been shown (VanGuilder et al., 2011).
Thus, we proposed that the promotion of hippocampal PSD-95
expression in middle-aged mice treated with RA could be one
of the plausible mechanisms by which RA treatment might exert
promnesic effects in the CSD task. In addition, we show that
RA treatment on middle-aged mice does not modify Synap-
tophysin, RC3, and GAP-43 hippocampal mRNA expression.
It has been demonstrated to date that RA treatment or vita-
min A supplementation can increase levels expression of RC3
(Etchamendy et al., 2001) and GAP-43 (Mingaud et al., 2008)
during aging. However, no effect of vitamin A supplementa-
tion nor RA treatment has been evidenced on hippocampal
GAP-43 mRNA expression in middle-aged mice (Mingaud et al.,
2008) suggesting thereby that the modulation of retinoid sta-
tus at mid-life would not be efﬁcient to induce changes in
these plasticity-related genes and would be more speciﬁc to
PSD-95.
EFFECTS OF RETINOIC ACID TREATMENT ON INTRAHIPPOCAMPAL
CORTICOSTERONE LEVELS: INVOLVEMENT OF RETINOIC ACID
RECEPTORS
In order to better understand somepotentialmechanisms involved
in the regulation of hippocampal plasticity and memory processes
in the CSD task by RA treatment, we have tested whether RA
signaling pathway could be a regulator of intrahippocampal CORT
levels in middle-aged mice. Our study shows that RA treatment
does not inﬂuence basal levels of intrahippocampal CORT but
reduces and delays the CORT rise after CSD-induced stress in
middle-aged mice.
Therefore, in order to establish a link between vitamin A sta-
tus in middle-aged mice and hippocampal CORT rise after stress
conditions, we measured the expression of hippocampal retinoid
receptors. We show that the low CORT release in middle-aged
RA-treated mice has been associated with a decrease in hippocam-
pal RARα and an increase in RARβ mRNA expression levels thus
showing that retinoid signaling could be an important modulator
of intrahippocampal GCs activity. It has been shown that the hip-
pocampal expression of retinoic receptors is a good indicator of
vitamin A status and intracellular availability of RA. Indeed, sev-
eral studies have demonstrated age-related decreases in mRNA
expression or protein levels of retinoid receptors in mice and
rat brain (Enderlin et al., 1997; Etchamendy et al., 2001; Feart
et al., 2005; Mingaud et al., 2008; Dyall et al., 2010) indicating
a decreased bioavailability of the ligand. More speciﬁcally, age-
induced decreased RARβ in the whole brain has been associated
withmemory deﬁcits and all these effects can be normalized by RA
treatment (Etchamendy et al., 2001). According to these results,
we evidence that RA treatment increases hippocampal expres-
sion of RARβ in middle-aged while RARα is decreased. More
importantly, we have shown correlations between hippocampal
expression of these retinoid receptors and hippocampal CORT
levels. Thus, our results suggested that RA treatment-induced
up-regulation of hippocampal RARβ but also down-regulation
of hippocampal RARα could contribute to limit hippocampal
CORT rise. These results further substantiated our hypothesis
of a close relationship between hippocampal retinoid and GC
pathways.
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POSSIBLE MECHANISMS INVOLVED IN THE EFFECTS OF RA
TREATMENT ON INTRAHIPPOCAMPAL CORT LEVELS
11β-HSD1 hypothesis
The magnitude of intracellular GCs action is thought to be deter-
mined by the activity of 11β-HSD1 (Seckl, 1997), that is increased
during aging in hippocampus and correlated with impaired cogni-
tive performance in the water maze (Holmes et al., 2010). Indeed,
11β-HSD1 regenerates active GCs from their inactive forms, in
speciﬁc areas in the adult brain, such as the hippocampus, thereby
effectively amplifying intracellular GC levels before they bind to
MRs and/or GRs (Holmes et al., 2003). Interestingly, inhibitory
effects of RA and vitamin A supplementation have been shown
on the expression and the activity of 11β-HSD1, in differenti-
ated C2C12 myotubes (Aubry and Odermatt, 2009), in obese rats
liver (Sakamuri et al., 2011) and in vitamin A deﬁcient rats hip-
pocampus (Arvy et al., 2013). Thus, we suggest that the effect
of RA treatment on hippocampal CORT levels could directly be
mediated, through retinoid receptors which act as transcription
factors. However, our results show that hippocampal 11β-HSD1
expression is not modulated by RA treatment in middle-aged mice
suggesting that other mechanisms would lead to a modulation of
hippocampal CORT levels.
Modulation of HPA axis
Another hypothesis would be a dysfunctioning of the HPA axis in
response to stress in middle-aged mice and a subsequent deregu-
lation of hippocampal CORT levels (Herman et al., 2001). Brain
aging has been construed as being conditioned by an excessive
plasma GC secretion leading to damages on brain areas, such as
hypothalamus or hippocampus, involved in the control of the
activity of the HPA axis (Cameron and Gould, 1994; Lupien et al.,
1998; Yau and Seckl, 2012). More recently, an increase in HPA axis
activity was shown in vitamin A deﬁcient rats LOU/C, exhibiting
retinoid hyposignaling pathway, leading to elevated total plasma
CORT level in basal and stress conditions, which is restored to
control level by RA treatment (Arvy et al., 2013). However, con-
trary to this result, it has been shown that chronic RA treatment
with high doses (2 mg/kg) induced a hyperactivation of HPA
axis along with an increased basal plasma CORT levels in young
rats (Cai et al., 2010). This discrepancy may be related to differ-
ences in treatment used (duration of RA injections, doses) and
nutritional status (vitamin A deﬁcient rats vs control rats). More-
over, an interesting recent study, has proposed that excessive RA
treatment could induce hyperactivation of HPA axis leading to
hypersecretion of plasma CORT through an increased hypotha-
lamic expression of RARα and a deﬁcient negative feedback at
the level of hypothalamic GR expression (Hu et al., 2013). In our
present study, elevated expression of RARα would also be deleteri-
ous and associated with an alteration in HPA axis. We can propose
that our more physiologic short-term RA treatment (150 μg/kg)
would lead to a normalization of HPA axis activity in middle-
aged mice probably via a regulation of hippocampal RARs and
GRs levels. However, the precise molecular mechanism by which
RA and GCs signaling interacts, awaits future study. Thus, alto-
gether these data suggested that vitamin A status would be an
important nutritional factor to take into account in the mod-
ulation of the CORT at systemic levels which probably would
impact on hippocampal availability of CORT (Yau and Seckl,
2012).
DOES RETINOIC ACID TREATMENT ACT ON HIPPOCAMPAL PLASTICITY
AND FUNCTIONS VIA GLUCOCORTICOIDS?
In the present study, we show that RA treatment has beneﬁcial
effects on hippocampal plasticity and functions at middle-age that
probably via the modulation of intrahippocampal CORT levels.
This hypothesis is also supported by the results of Tronche et al.’s
(2010) study showing that the stress-induced hippocampal CORT
levels in middle-aged mice were of greater magnitude as com-
pared to young mice, and that a metyrapone (an inhibitor of
CORT synthesis) injection before stress blocked both the stress-
induced hippocampal CORT rise and associated memory retrieval
impairment. GCs can promote behavioral adaptation, regulating
(either enhancing or impairing) several memory processes (Joels,
2008). For example, stress can enhance the consolidation of spa-
tial and emotional memories, but it can also impair their retrieval
(de Quervain et al., 1998; Sandi and Pinelo-Nava, 2007). Thus,
insofar as it has been shown that the effectiveness of learning
throughout a continuum of stress and/or CORT levels gener-
ally follows an inverted U-shaped function (Salehi et al., 2010),
we may hypothesize therefore that RA treatment could normalize
stress levels in middle-aged mice during CSD task. Interestingly
this hypothesis ﬁts well with a previous study from our group
having shown that the administration of diazepam inhibited the
stress-induced increase of hippocampal CORT levels and in par-
allel, restored memory performance in the CSD task (Beracochea
et al., 2011). Finally, a recent study has found a decrease in hip-
pocampal PSD-95 protein levels after chronic CORT exposure
(Cohen et al., 2011). Thus, PSD-95 seems to be a good plasticity-
related RA and GCs target genes that could be involved, at least
in part, in the positive effects of RA treatment on hippocampal
functions.
CONCLUSION
The present study provides breakthrough evidence that RA
treatment can decrease and delay the stress-induced intrahip-
pocampal CORT rise in middle-aged mice. Moreover, correlations
between vitamin A status evaluated by the hippocampal expres-
sion of retinoid receptors and CORT levels in the hippocampus
have been evidenced. Interestingly, our data suggest that the
improvement of memory and hippocampal plasticity in RA-
treated mice could result from a decreased hippocampal CORT
rise but future investigations are needed to establish a clear-
cut causal link. Since vitamin A metabolism alterations occur
during aging, our results are of prime importance and further
substantiate the view that maintaining a normal vitamin A sta-
tus in seniors would be crucial to prevent age-related cognitive
impairments.
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